News & Events

In the News

August 10, 2021
Activating SCN1A to Treat Dravet Syndrome
GeneTherapyLive
April 23, 2021
40 Under 40 Class of 2021
San Francisco Business Times
October 28, 2020
Startup Spotlight: Encoded eyes a gene therapy for Dravet syndrome
STAT

Media Kit

Logo

Leadership Photos

Kartik Ramamoorthi, Ph.D.
Encoded Co-Founder, CEO and Board Member
Stephanie Tagliatela
Encoded Co-Founder, Chief Scientific Officer and Board Member
Salvador Rico, M.D., Ph.D.
Encoded Chief Medical Officer